Suppr超能文献

双氯芬酸葡萄糖醛酸苷的选择性蛋白加合物形成严重依赖于大鼠胆小管共轭物输出泵(Mrp2)。

Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2).

作者信息

Seitz S, Kretz-Rommel A, Oude Elferink R P, Boelsterli U A

机构信息

Institute of Toxicology, Swiss Federal Institute of Technology and University of Zurich, Schorenstrasse 16, CH-8603 Schwerzenbach, Switzerland.

出版信息

Chem Res Toxicol. 1998 May;11(5):513-9. doi: 10.1021/tx970203+.

Abstract

Previous work demonstrates that the reactive acyl glucuronide of the nonsteroidal antiinflammatory drug diclofenac forms selective protein adducts in the liver, which may play a causal role in the pathogenesis of diclofenac-associated liver toxicity. Because glucuronide conjugates can be exported into the bile, we explored the role of diclofenac glucuronide hepatobiliary transport in the formation of site-specific protein adducts. Specifically, to analyze intracellular (hepatocytes) versus extracellular (biliary tree) targeting of proteins, we have compared the pattern of diclofenac binding in normal Wistar rats with that in mutant transport-deficient (TR-) rats which lack the functional canalicular isoform of the conjugate export pump, Mrp2. In bile duct-cannulated normal rats, >50% of an iv injected dose of [14C]diclofenac appeared in the bile over a 90-min period. In contrast, in TR- rats virtually no hepatobiliary excretion of diclofenac glucuronide was found. After administration of diclofenac (30 mg/kg/day, ip for 3 days) to rats of both genotypes, a major protein adduct of an apparent molecular mass of 118 kDa was selectively detected by immunoblotting in isolated canalicular, but not in basolateral, membrane subfractions of wild-type rats, whereas no plasma membrane adducts could be found in the livers of TR- rats. Furthermore, immunohistochemical analysis using an anti-diclofenac antibody revealed the presence of distinct diclofenac-modified proteins on canalicular membranes of liver sections from diclofenac-treated normal rats, whereas no adducts could be identified in livers of TR- rats. In Western blots, the major diclofenac-modified canalicular membrane protein did not comigrate with Mrp2, indicating that the glucuronide carrier itself was unlikely to be a target. Collectively, the results demonstrate that the reactive diclofenac glucuronide is selectively transported into bile via Mrp2 and that hepatobiliary transport is critical for diclofenac covalent binding to proteins in the biliary tree.

摘要

先前的研究表明,非甾体抗炎药双氯芬酸的反应性酰基葡萄糖醛酸在肝脏中形成选择性蛋白质加合物,这可能在双氯芬酸相关肝毒性的发病机制中起因果作用。由于葡萄糖醛酸缀合物可排入胆汁,我们探讨了双氯芬酸葡萄糖醛酸肝胆转运在特异性蛋白质加合物形成中的作用。具体而言,为了分析蛋白质在细胞内(肝细胞)与细胞外(胆管树)的靶向作用,我们比较了正常Wistar大鼠与缺乏共轭物输出泵Mrp2功能性胆小管异构体的突变转运缺陷(TR-)大鼠中双氯芬酸的结合模式。在胆管插管的正常大鼠中,静脉注射剂量的[14C]双氯芬酸在90分钟内超过50%出现在胆汁中。相比之下,在TR-大鼠中几乎未发现双氯芬酸葡萄糖醛酸的肝胆排泄。对两种基因型的大鼠给予双氯芬酸(30mg/kg/天,腹腔注射3天)后,通过免疫印迹在野生型大鼠分离的胆小管而非基底外侧膜亚组分中选择性检测到一种表观分子量为118kDa的主要蛋白质加合物,而在TR-大鼠的肝脏中未发现质膜加合物。此外,使用抗双氯芬酸抗体的免疫组织化学分析显示,双氯芬酸处理的正常大鼠肝脏切片的胆小管膜上存在不同的双氯芬酸修饰蛋白,而在TR-大鼠的肝脏中未鉴定出加合物。在蛋白质免疫印迹中,主要的双氯芬酸修饰胆小管膜蛋白与Mrp2不同步迁移,表明葡萄糖醛酸载体本身不太可能是靶点。总的来说,结果表明反应性双氯芬酸葡萄糖醛酸通过Mrp2选择性转运到胆汁中,并且肝胆转运对于双氯芬酸与胆管树中蛋白质的共价结合至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验